“Global Oligonucleotide Synthesis Market By End User (Academic Research Institutes, Pharmaceutical, and Biotechnology Companies, Diagnostic Laboratories, Others), By Application (Research, Diagnostics, Therapeutics), By Products and Services (Synthesized Oligonucleotides, Reagents, Equipment) and Region- Global Market Size, Status and Forecast to 2026″, published by Verified Market Research.

The Global Oligonucleotide Synthesis Market size is projected to grow from USD 1,561.6 Million in 2018 to USD 3,401.3 Million by 2026, at a CAGR of 10.45% from 2019 to 2026. Increasing R&D expenditure in pharmaceutical and biotechnology companies is expected to support market growth during the forecast period.

Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=15651&utm_source=Free&utm_medium=004

Browse in-depth TOC on “Global Oligonucleotide Synthesis Market”

45 – Tables
32 – Figures
82 – Pages

On the basis of products & services, the market is bifurcated into Synthesized Oligonucleotides, Reagents, and Equipment. Synthesized Oligonucleotides accounted for the largest market share of the global oligonucleotide synthesis market. Oligonucleotide synthesis can be defined as the chemical synthesis of short fragments of nucleic acids with a defined chemical structure. They have provided an opportunity to produce genes for proteins that do not naturally exist. Combining this with X-ray and NMR techniques have made it possible to see 3D protein structures.

Technological advancements and R&D investments in synthetic biology are expected to drive the market. Synthetic biology is emerging as a vital field that has the potential to impact a large number of academic and industrial applications including the creation of novel therapeutics, biosensing, materials, and manufacturing capabilities. As of now, the build of biological systems requires a large amount of empirical trial and error to evaluate novel enzymes, expression systems, and pathways for the desired function. This is typically carried out through designing a desired synthetic biological pathway using computer-aided design tools.

Get More Information @ – https://www.verifiedmarketresearch.com/download-sample/?rid=15651&utm_source=Free&utm_medium=004
The North America region is projected to account for the largest share in the Global Oligonucleotide Synthesis market during the forecast period.

The United States has a rising number of initiatives for governments funding for the advancement of activities such as drug discovery, antibody production and disease research. With the increase in the potential for oligonucleotide therapeutic drug development, the region is seen to place increasing emphasis on research and development, aiding the growth of the Oligonucleotides Synthesis market in this region.
Key players
Integrated DNA Technologies, Inc., Merck KGaA, Eurofins Genomics, BioAutomation, Agilent Technologies Inc., Eurogentec S.A. are the key players operating in the Global Oligonucleotide Synthesis market. Acquisitions and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Global Oligonucleotide Synthesis Market.

Obtain Report Details @ https://www.verifiedmarketresearch.com/press-release/oligonucleotide-synthesis-market/?utm_source=Free&utm_medium=004